Filing Details

Accession Number:
0001831283-23-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-05 16:29:37
Reporting Period:
2023-01-03
Accepted Time:
2023-01-05 16:29:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1831283 Lianbio LIAN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1880938 Jiang Qian C/O Lianbio, 103 Carnegie Center Drive
Suite 309
Princeton NJ 08520
Svp, China General Manager No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2023-01-03 2,239 $1.65 67,349 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sale of shares to cover personal income tax obligations upon vesting of restricted share units as required pursuant to the terms of Mr. Qian's restricted share unit award agreement.